Stephen Willey
Stock Analyst at Stifel
(3.85)
# 658
Out of 5,127 analysts
126
Total ratings
41.94%
Success rate
13.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintains: Buy | $30 → $40 | $23.10 | +73.16% | 7 | Nov 19, 2025 | |
| CELC Celcuity | Maintains: Buy | $68 → $115 | $104.67 | +9.87% | 2 | Nov 13, 2025 | |
| NKTX Nkarta | Maintains: Buy | $12 → $11 | $2.11 | +421.33% | 5 | Nov 11, 2025 | |
| IRON Disc Medicine | Reinstates: Buy | $125 | $79.29 | +57.65% | 1 | Nov 3, 2025 | |
| ACLX Arcellx | Reinstates: Buy | $129 | $64.31 | +100.59% | 1 | Oct 16, 2025 | |
| INCY Incyte | Maintains: Buy | $110 → $115 | $105.92 | +8.57% | 7 | Sep 22, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $4.04 | +122.77% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $170.27 | -14.84% | 8 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $4.11 | +70.32% | 7 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $44.15 | -7.13% | 19 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.97 | +155.24% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $5 | $1.79 | +179.33% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $5.81 | +244.23% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $35 | $18.63 | +87.87% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $12.78 | +682.47% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.37 | +191.97% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $16.56 | +183.82% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.39 | +918.07% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.64 | +143.90% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $41.22 | +50.41% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.17 | +74.08% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.89 | +534.92% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.61 | +17,788.20% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.57 | +717.12% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.18 | +238.98% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $399.40 | -69.20% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $81.54 | -42.36% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $60.35 | +80.61% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $19.65 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $8.85 | +159.89% | 5 | Feb 7, 2018 |
Zymeworks
Nov 19, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $23.10
Upside: +73.16%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $68 → $115
Current: $104.67
Upside: +9.87%
Nkarta
Nov 11, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $2.11
Upside: +421.33%
Disc Medicine
Nov 3, 2025
Reinstates: Buy
Price Target: $125
Current: $79.29
Upside: +57.65%
Arcellx
Oct 16, 2025
Reinstates: Buy
Price Target: $129
Current: $64.31
Upside: +100.59%
Incyte
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $115
Current: $105.92
Upside: +8.57%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $4.04
Upside: +122.77%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $170.27
Upside: -14.84%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.11
Upside: +70.32%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $44.15
Upside: -7.13%
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $10.97
Upside: +155.24%
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.79
Upside: +179.33%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $5.81
Upside: +244.23%
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $18.63
Upside: +87.87%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $12.78
Upside: +682.47%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.37
Upside: +191.97%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $16.56
Upside: +183.82%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.39
Upside: +918.07%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.64
Upside: +143.90%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $41.22
Upside: +50.41%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $5.17
Upside: +74.08%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.89
Upside: +534.92%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.61
Upside: +17,788.20%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.57
Upside: +717.12%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.18
Upside: +238.98%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $399.40
Upside: -69.20%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $81.54
Upside: -42.36%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $60.35
Upside: +80.61%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $19.65
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $8.85
Upside: +159.89%